A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z)
Clinical trial NCT03583606 · COMPLETED
Trial details
- NCT number
- NCT03583606
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-12
- Primary completion
- 2020-01-14
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.